Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROCKIF Trial: VS-6063, Carboplatin, and Paclitaxel in Ovarian Cancer
NCT03287271Phase 2Terminated
- Start
- Feb 2018
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of defactinib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC). Started Feb 2018; status: terminated.
02
Drugs
defactinib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT03287271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03287271.